Global Product Development Lead (Early-Stage)

Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases. See Yourself at Telix The Global Development Lead will be responsible for progressing a molecularly targeted radiation therapy through clinical trials up to and including Phase 2. The role will be responsible for creating, implementing, managing and executing the drug development plan. The successful delivery of the development plan will require leading a cross-functional team (including manufacturing, non-clinical, clinical, quality and regulatory) and will need a strong understanding of oncology drug development. This role is critical to accelerate the delivery of a potential pan-cancer therapy towards registration. Key Accountabilities: Work as part of a cross-functional team to create/manage a Target Product Profile and Product Development plan for the targeted therapy in solid tumours. Lead cross-functional teams to deliver the program development milestones up to the end of Phase 2 clinical evaluation within project timelines and budget. Act as the primary point of contact for the program and ensure that excellent communication is maintained both internally and externally. Oversight of a Project Manager to ensure application of project management best practice. Complete oversight of the delivery of product development plans, more specifically: Maintenance of up-to-date documentation of product positioning and target product profile. Progress tracking of